Anthropic's IPO Path Hits Safety Turbulence

Two fresh friction points landed on Anthropic’s IPO timeline this week: a public safety alarm from inside the company’s own alignment team, and a belated but symbolically significant gesture toward EU regulators.

Key points

• An Anthropic alignment researcher publicly stated a greater-than-10% probability of AI-caused human extinction, and a colleague resigned, according to The Information.
• The episode risks rattling prospective IPO investors and drawing additional regulatory scrutiny ahead of the road show.
• Separately, Anthropic has granted the EU’s cybersecurity agency access to its Mythos model for security testing, months after first promising to do so.
• The Mythos access grant signals a push to get ahead of European AI regulation, though the delayed timeline may itself invite questions.
• Both developments arrive on top of existing pricing pressure from OpenAI, compounding the narrative challenges Anthropic faces as it prepares to file.

Does an internal safety alarm change the IPO calculus?

The core problem for Anthropic’s bankers is one of mixed messaging. The company has long marketed its safety-first identity as a commercial differentiator, not just a philosophical stance. That framing holds up reasonably well when safety credentials attract enterprise customers and regulators. It becomes harder to manage when the same safety culture produces a researcher willing to put a double-digit extinction probability estimate into public circulation.

The Information reports that the researcher’s warning and a colleague’s subsequent resignation are already viewed inside the company as complications for the upcoming road show and political outreach. Institutional investors running standard risk-assessment frameworks are accustomed to operational and competitive risks. Existential risk framed in probabilistic terms by a current or recent employee is a harder line item to process, and harder still to dismiss when it comes from someone with direct knowledge of the underlying models.

The resignation adds another layer. A departure during the IPO preparation window, tied publicly to safety concerns, gives journalists and regulators a human story to attach to what might otherwise remain an abstract debate. Whether or not the concerns reflect anything materially new about Anthropic’s technology, the optics land at a sensitive moment.

What the EU cybersecurity access actually signals

Bloomberg reports that Anthropic has now granted the EU cybersecurity agency the ability to review and security-test Mythos, its flagship model. The access was promised earlier and has only now been delivered, months later.

The practical effect is that EU regulators can conduct independent security assessments of Mythos rather than relying solely on Anthropic’s own disclosures. For a company preparing to go public, that kind of third-party validation is generally useful: it demonstrates a willingness to submit to oversight and builds credibility with governments that are writing the rules Anthropic will operate under.

The delay, though, cuts the other way slightly. Anthropic committed to this access and then took months to deliver it. That gap will not go unnoticed in Brussels, and it hands critics an easy line of attack during a period when the company can least afford reputational friction in key markets.

Taken together, the EU move looks like a genuine attempt to repair or cement regulatory relationships ahead of the IPO rather than a routine compliance step. Timing matters here: getting the access grant completed and into the public record before the road show begins is clearly preferable to leaving it outstanding.

The compounding problem

None of these stories exists in isolation. Anthropic enters the IPO stretch with its pricing power under question following OpenAI’s recent cuts, an internal safety debate that has gone public, and a regulatory relationship in Europe that required prompting to fulfill a prior commitment.

Each of these, individually, is manageable. The concern for investors and underwriters is the pattern. A company can absorb competitive pricing pressure, or navigate a public safety debate, or explain a regulatory delay. Absorbing all three simultaneously, while trying to set a valuation and build a book, demands an unusually disciplined road show narrative.

What Anthropic has going for it is that none of today’s developments fundamentally alters its technology position or its revenue base. The EU access grant, whatever the delay, is now done. The alignment researcher’s statement reflects a view that has been part of the AI safety discourse for years. The question is whether institutional buyers price these as noise or as signal ahead of what is shaping up to be one of the most scrutinized technology IPOs in recent memory.